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OBJECTIVES We sought to evaluate the early and late results of the modified Fontan operation for patients
with heterotaxy syndrome, assess variables traditionally known to correlate with poor
outcome, and assess current health status of survivors after the Fontan procedure.
BACKGROUND The natural history of unoperated cardiac lesions in heterotaxy is known to be poor. Therefore, the
Fontan operation has been proposed to improve survival.
METHODS Patients with heterotaxy were identified from the Mayo Clinic Fontan database. Hospital
and outpatient records were abstracted for preoperative, operative, and postoperative clinical
and hemodynamic data. All patients not known to be deceased were sent health status
questionnaires.
RESULTS A total of 142 patients with heterotaxy syndrome had a modified Fontan operation. Asplenia
was present in 76 patients (54%). Median age at operation was 9 years (range 2 to 35 years).
Median follow-up was 4 years (range 0 to 23 years). There were a total of 61 deaths (43%),
with 32 (23%) within 30 days of operation or before hospital discharge. The 5-, 10-, and
15-year survival was 64%, 57%, and 53%, respectively. In the modern era (1995 to 2004)
early mortality was 10%. Of the 81 survivors, questionnaires were available from 41
(51%). Eighty percent reported having no or mild symptoms. However, 19 (46%) had
arrhythmias, 5 (12%) had a thromboembolic event, and 1 (2%) developed protein-losing
enteropathy.
CONCLUSIONS Early survival has improved for heterotaxy patients after the Fontan operation; however, late
morbidity and mortality remain substantial. Better strategies for long-term treatment of this
high-risk group need to be identified. (J Am Coll Cardiol 2006;48:2301–5) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.053American College of Cardiology Foundation
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8he natural history of patients with complex cardiac lesion
nd heterotaxy is poor. The 1-year mortality is 85% for
atients with asplenia and50% for patients with polysple-
ia (1,2). The modified Fontan operation has been used to
mprove survival in patients with heterotaxy syndrome and
unctional single ventricle. Due to complex venous and situs
nomalies, the technical aspects of constructing the path-
ays for a modified Fontan connection are complicated.
requently, conduits and baffles are necessary to effectively
ivert caval, hepatic, and pulmonary venous blood flows.
nitial reports of the outcome of the modified Fontan
peration for heterotaxy syndrome revealed early mortality
f 13% to 80% (3–6).
Since these early reports, there have been numerous
mprovements in surgical and postoperative techniques. We
ought to evaluate the early and late results of the modified
ontan operation for patients with heterotaxy syndrome.
From the Divisions of *Pediatric Cardiology, †Cardiovascular Diseases and
nternal Medicine, ‡Department of Thoracic and Cardiovascular Surgery, and
Section of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota.
his study was funded by the Department of Pediatric and Adolescent Medicine,
ayo Clinic.t
Manuscript received March 20, 2006; revised manuscript received June 23, 2006,
ccepted July 3, 2006.ariables traditionally known to correlate with poor out-
ome were assessed. Current health status of survivors was
btained.
ETHODS
atients. A total of 142 patients with heterotaxy syn-
rome were identified in the Mayo Clinic Fontan data-
ase from 1975 through 2004. No patients with hetero-
axy syndrome who had a Fontan procedure were
xcluded. Hospital and outpatient records were ab-
tracted for preoperative, operative, and postoperative
linical and hemodynamic data. Additionally, all patients
ho were not known to be deceased were sent health
tatus questionnaires. Current addresses and date of
eath were cross-referenced with Accurint, a locate-and-
esearch database. Patients who did not return their
uestionnaires after the first mailing received 2 additional
ailings and a reminder by telephone. The median age at
ontan procedure was 9 years (range: 2 to 35 years) with
2 (58%) being male. Median follow-up was 4.5 years;
he longest was 23 years.
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Modified Fontan Operation for Heterotaxy Syndrome December 5, 2006:2301–5natomy. Asplenia was diagnosed in 76 patients (54%)
nd polysplenia in 66 (46%) (Table 1). Ambiguous
bdominal situs was the most frequent type of visceral
itus (76%). Levocardia (56%) was slightly more common
han dextrocardia (42%). The majority of patients had a
ommon atrioventricular valve (79%). The ventricular
orphology was usually unbalanced, with 70% having
on-left ventricular morphology. Anomalous pulmonary
enous connections were present in 64% of patients.
bnormalities of the systemic venous connections also
ere common. Bilateral superior vena cavae (SVC) were
ound in 75 (53%) patients. Interruption of the inferior
ena cava (IVC) with azygos or hemiazygos continuation
o the SVC was present in 75 patients (54%). The hepatic
eins entered the atrium separate from the IVC in 79
ases (57%).
ras of operation. The 30-year study period was divided
nto 3 equal chronologic eras based on the date of the
Abbreviations and Acronyms
AV  atrioventricular
IVC  inferior vena cava
SVC  superior vena cava
Table 1. Anatomy
Anatomy
Asplenia
(n  76)
Visceral situs
Solitus 4
Inversus 6
Ambiguous 66
Cardiac position
Levocardia 41
Dextrocardia 34
Mesocardia 1
AV valve anatomy
Common 70
Left atresia 1
Right atresia 1
Normal 4
Ventricular morphology
Two ventricles of equal size 8
Left dominant 17
Right dominant 37
Indeterminate 14
Pulmonary venous connections
Normal 20
Total anomalous 45
Partial anomalous 11
IVC connection
Atrium 49
Azygos/hemiazygos to SVC 26
SVC location
Right 25
Left 18
Bilateral 33
Hepatic venous connections
IVC 42
Separate 32AV  atrioventricular; IVC  inferior vena cava; SVC  superioontan operation. The early era, 1975 through 1984,
ncluded 30 patients. The majority of operations were
erformed during the middle era, 1985 through 1994, with
1 patients. An additional 21 patients had the operation in
he most recent era, 1995 through 2004 (Fig. 1). There was
o statistically significant difference between eras in age at
urgery, gender, or number of previous surgical palliations
Table 2).
revious palliative procedures. For 22 patients (16%), the
ontan operation was their first surgical procedure. Seventy-
ine patients (56%) had 1 previous palliative procedure, 30
21%) had 2, and 11 (8%) had 3 (Table 3).
ontan connection. The types of Fontan connections that
ere used are listed in Table 4. Only 6 patients had a
enestration, and all of those were performed in the recent
ra. Atrioventricular (AV) valve replacement was performed
n 8 patients (6%) and repaired in 37 patients (26%) at the
ime of the Fontan procedure.
tatistical analysis. We used the same independent vari-
bles of interest that were used in previous outcome studies
f the Fontan operation from the Mayo Clinic (3,4,7–9).
nivariate assessment of the association of variables with
ortality was performed using chi-square and Wilcoxon
ank sum tests. Cumulative survival was estimated using the
Polysplenia
(n  66)
Total
(n  142) Percent
10 14 10
14 20 14
42 108 76
39 80 56
25 59 42
2 3 2
41 111 79
7 8 6
5 6 4
11 15 11
9 17 12
9 26 18
36 73 51
12 26 18
31 51 36
20 65 46
14 25 18
16 65 46
49 75 54
9 34 24
14 32 23
43 76 53
17 59 43
47 79 57r vena cava.
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December 5, 2006:2301–5 Modified Fontan Operation for Heterotaxy Syndromeaplan-Meier method. Models were constructed with Cox
roportional-hazard models using a stepwise elimination of
he nonsignificant variables performed using a p value cut
oint to retain variables 0.05. For all other comparisons,
-tail p values of 0.05 were taken as evidence of findings
ot attributable to chance.
ESULTS
arly mortality. Overall, 32 patients (23%) died within 30
ays after operation or before hospital discharge. Early
ortality decreased over time, from 50.0% in the early era to
6.5% in the middle era and 9.5% in the most recent era.
omparing the early era with both the middle (p  0.001)
nd the recent eras (p  0.003), there has been a significant
ecrease in early mortality. Comparing the middle era to the
ecent era, there is a trend toward decreased mortality, but
t is not statistically significant (p  0.42). No early deaths
ccurred in 6 patients who had fenestration as part of the
ontan procedure (all performed in the most recent era).
nivariate predictors of early mortality. The variables
hat correlated significantly with early mortality were a
reoperative cardiothoracic ratio 0.6, elevated systemic
entricular end-diastolic pressure, prolonged bypass time,
ostoperative mean right atrial pressure 20 mm Hg, and
ostoperative renal failure (Table 5).
ate mortality. Using a combined approach of chart review
nd Accurint searches, 29 late deaths were identified,
anging from 97 days to 20 years after operation. The cause
f death was known in 19 cases. Five patients died after late
eoperation, 4 with asplenia died from sepsis, 4 were sudden
nd presumed due to an arrhythmia, 3 were attributed to
rogressive myocardial failure, 1 to pulmonary hemorrhage,
to suicide, and 1 to a motor vehicle accident. Clinical or
utopsy data could not be obtained for 10 of the 29 patients.
igure 1. Number of Fontan operations performed at Mayo Clinic for
eterotaxy syndrome.
Table 2. Demographics Based on Era of Oper
Variable Overall 1975
Asplenia 76 (54%) 12 (
Gender (male) 82 (58%) 20 (
Age, yrs (range) 9 (2–35) 9 (
Prior palliative procedures 1 (0–4) 1 (0–3)owever, accurate dates of death were available for all 29
atients.
Actuarial cumulative survival at 5, 10, and 15 years was
4%, 57%, and 53%, respectively. In the early surgical era,
arly mortality was high (50%) and cumulative long-term
urvival was poor (33%, 33%, and 30% at 5, 10, and 15
ears, respectively). Early- and long-term survival improved
n the 2 more recent eras. Combining only the 2 most recent
ras, the 5-, 10-, and 15-year survival was 72%, 63%, and
0%, respectively (Fig. 2).
nivariate predictors of late mortality. Only bypass time
120 min and AV valve replacement were predictive of
ate mortality, with odds ratios of 5.59 and 6.24, respec-
ively (p  0.05).
urrent health and functional status. Excluding the 32
arly deaths and the 29 late deaths, there were 81 (57%) late
urvivors available to assess current health and functional
tatus. Follow-up data were obtained for 41 (51%) of these
atients by written questionnaire or by return clinic visit
uring the data acquisition portion of this study. For these
1 patients, the median follow-up interval after the Fontan
peration was 15 years (range 1 to 23 years). Of these
atients, 80% reported having no or mild symptoms with
rdinary physical activity, 18% had moderate symptoms
ith less than normal physical activity, and 3% had symp-
oms at rest. Specific signs and symptoms consisted of easy
atigue (49%), palpitations (39%), shortness of breath
32%), persistent cyanosis (24%), and chest pain (20%).
Despite this optimistic self-reported current health status,
hese 41 patients had numerous medical complications.
ineteen patients (46%) reported a history of an arrhythmia
nd 9 (22%) required placement of a permanent pacemaker.
thromboembolic event occurred in 5 patients (12%).
rotein-losing enteropathy was diagnosed in 1 patient (2%).
ne patient had cardiac transplantation (lateral tunnel), 1
as currently listed for transplant (right ventricular outflow
ract to pulmonary artery), and 1 was being evaluated for
ransplantation (Kawashima-type connection).
Most (95%) of these 41 patients were taking1medication.
he most frequent medications included angiotension-
onverting enzyme inhibitors or angiotensin II receptor block-
rs (73%), digoxin (66%), daily antibiotic prophylaxis (53%),
spirin (54%), warfarin (43%), beta-blocker (24%), and aldac-
one (18%). Of the patients with asplenia, 81% were taking
aily antibiotic prophylaxis.
Most survivors (78%) were employed or attending formal
ducation programs at the time of this review. Of those
mployed, 50% were working full time. Part-time employ-
4 1985–1994 1995–2004 p Value
) 49 (53.9%) 15 (71.4%) NS
) 54 (59.3%) 8 (38.1%) NS
10 (2–35) 5 (2–24) NSation
–198
40.0%
66.7%
3–19)1 (0–4) 1 (0–3) NS
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Modified Fontan Operation for Heterotaxy Syndrome December 5, 2006:2301–5ent was by choice in 28% of those employed, and 22%
ere limited to part-time employment by their current
ardiac status.
ISCUSSION
efore the concept of total right heart bypass to treat
ricuspid atresia, patients with heterotaxy and functional
ingle ventricle were only candidates for palliative proce-
ures to either augment or restrict pulmonary blood flow.
ven after the description of the Fontan operation, the
riteria developed by Choussat et al. (10) essentially ex-
luded patients with heterotaxy syndrome from having a
ontan operation. However, clinicians expanded the indi-
ations and in the mid-1970s the Fontan operation was used
o treat patients with all forms of complex functional single
entricle, including patients with heterotaxy syndrome.
nfortunately the mortality for patients with heterotaxy
ho had a Fontan operation was high. Humes et al. (4)
eported an early mortality of 43%. In early outcome series
fter the Fontan operation, heterotaxy frequently was one
ariable that predicted poor outcome (7).
Investigators in the 1980s recognized that heterotaxy
er se may not have been the most critical variable that
redicted high mortality. Rather, the more important fac-
ors relating to mortality were poor ventricular function, AV
alve regurgitation, and complex surgical repair with pro-
onged bypass time (7). Investigators believed that the
ontan operation could be successful for patients with
eterotaxy if the operation was performed before develop-
ent of ventricular dysfunction and/or significant AV valve
nsufficiency. Surgical techniques improved over time, per-
itting shorter duration of cardiopulmonary bypass.
In the present study, several recognized risk factors for
arly mortality (AV valve repair, decreased ventricular sys-
able 3. Prior Palliative Procedures
Procedure n
lalock-Taussig shunt 90 (63%)
avopulmonary anastamosis 20 (14%)
aterston shunt 16 (11%)
trial septectomy 13 (9%)
ulmonary artery band 11 (8%)
otts shunt 4 (3%)
otal 154
able 4. Type of Fontan Connection
Procedure n
ateral tunnel 75 (53%)
irect RA-PA 16 (11%)
ntra-atrial conduit 15 (11%)
xtracardiac conduit 13 (9%)
trial appendage to PA 11 (8%)
awashima 10 (7%)
VOT-PA 1 (1%)
5-mm Hancock conduit (RA-PA) 1 (1%)F
p
A  pulmonary artery; RA-PA  right atrium to pulmonary artery; RVOT-PA 
ight ventricular outflow tract to pulmonary artery.olic function, and elevated pulmonary arteriolar resistance)
ere not predictive of outcome. Similar experience has been
eported in other recent series (3,8,11,12). This may be due
o several factors, such as better patient selection, staged
epair, advancement of surgical techniques, and improved
ostoperative management. Despite these encouraging re-
ults, children with functional single ventricle and total
nomalous pulmonary venous connections have a 53%
ortality at the time of initial palliative operation, and the
ortality for the subsequent cavopulmonary anastomosis
lso is substantial (38%) (13). Therefore, many “high-risk”
atients with heterotaxy and functional single ventricle may
ever reach the age to have a Fontan operation (14,15).
Atrioventricular valve repair or replacement previously
as been associated with early mortality (3). Therefore,
linical practice has evolved and led to AV valve repair/
eplacement before completion of the Fontan connection.
n the current cohort, AV valve repair or replacement was
ot predictive of early mortality, which may be an important
actor resulting in improved early mortality.
able 5. Variables Associated With Early Mortality
Factors
Univariate
p Value Odds Ratio (CI)
reoperative
Cardiothoracic ratio 0.6 0.05 2.51 (1.01–6.25)
End-diastolic pressure (mm Hg) 0.05 1.10 (1.01–1.19)
AV valve regurgitation NS
Ejection fraction NS
Mean PAP 20 mm Hg NS
Rpa 4 U m2 NS
perative
Bypass time (min) 0.01 1.01 (1.00–1.02)
AV valve repair/replace NS
APVC repair NS
ostoperative
Mean RA pressure 20 mm Hg 0.05 3.92 (1.38–11.1)
Renal failure 0.0001 39.2 (11.0–138.8)
Chest tube drainage 14 days NS
PVC  anomalous pulmonary venous connection; AV  atrioventricular; CI 
onfidence interval; PAP  pulmonary arterial pressure; RA  right atrium; Rpa 
ulmonary arterial resistance.igure 2. Kaplan-Meier curve depicting the survival after the Fontan
rocedure for patients with heterotaxy syndrome.
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December 5, 2006:2301–5 Modified Fontan Operation for Heterotaxy SyndromeThe types of Fontan connection have evolved over the past
0 years. Also, because of the complex anatomy associated with
eterotaxy the methods of accomplishing the Fontan connec-
ions are quite varied among patients with heterotaxy. This
akes it difficult to determine the relationship between the
ype of Fontan procedure and outcome.
In the recent era (1995 to 2004), early mortality after
ontan decreased to 9.5% but remained greater than the
arly mortality for patients with double-inlet left ventricle
nd tricuspid atresia (3% and 2%, respectively) during a
imilar time period at the Mayo Clinic (8,9). Because early
ortality for patients with heterotaxy syndrome remains
ubstantially higher than for patients with other forms of
unctional single ventricle, one may propose that all patients
ith heterotaxy syndrome who have a Fontan operation
hould also have a fenestration performed. Currently, at our
enter, patients with heterotaxy syndrome have Fontan
ompletion via a fenestrated intra-atrial Gore-Tex tube
onduit. The long-term benefits of this technique merit
urther analysis.
It has been argued that the improvements in the care and
utcome of patients with functional single ventricle may not
ranslate into improved results for heterotaxy patients. It
as thought that their numerous associated anatomic and
hysiologic maladies would negate these advances. Al-
hough results have not reached the level seen in double-
nlet left ventricle or tricuspid atresia, survival for heterotaxy
atients has clearly improved. It is also encouraging to note
hat of the 76 patients with asplenia, only 4 died late of
linical sepsis. We were unable to ascertain antibiotic prophy-
axis status in these 4 patients, however, in the surveyed
atients with asplenia, 19% were not taking antibiotic prophy-
axis, which may be a contributing risk factor.
Rhythm disturbances account for a substantial degree of
orbidity and mortality. Arrhythmias were reported in 46%
f the patients with heterotaxy compared with 57% of
atients with double-inlet left ventricle (8). Because patients
ith heterotaxy undergo extensive intra-atrial baffling pro-
edures, one might anticipate a higher incidence of arrhyth-
ia than for patients having less extensive atrial surgery. We
id not find this to be true. However, the patients with
eterotaxy had a shorter follow-up interval (4 vs.12 years)
han the patients with double-inlet left ventricle. Longer
ollow-up may demonstrate that patients with heterotaxy
ave an even higher risk of sudden death and arrhythmias
han patients with less complex forms of functional single
entricle. Thus, a detailed and aggressive approach to
urveillance and therapy for arrhythmias is essential.
Survival after the Fontan operation for patients with
eterotaxy has improved despite the anatomic complexity of
heir cardiac disease. Many factors have contributed to the
mproved survival. In our assessment of long-term survival
any of these factors were subtle and evolved simulta-
eously. This made it difficult in the retrospective statistical
nalysis to delineate specific factors that affect outcome. It isost likely that improved patient selection, staging of
urgical repair, younger age at time of Fontan operation,
efinements in surgical techniques, and advancement of
ostoperative care have all contributed to the improved
esults.
onclusions. Over the past 30 years, there has been a
ignificant improvement in the early outcome for patients
ith heterotaxy syndrome after a modified Fontan opera-
ion. However, mortality and morbidity remain substantial.
iscovery of innovative treatment methods is essential.
urthermore, meticulous long-term medical management at
enters specializing in the care of congenital heart disease is
andatory.
eprint requests and correspondence: Dr. Frank Cetta, Division
f Pediatric Cardiology, Mayo Clinic College of Medicine, 200
irst Street SW, Rochester, Minnesota 55905. E-mail: cetta.
rank@mayo.edu.
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